Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2
Authors:
- Kamila GromekKamila Gromek
- William HawkinsWilliam Hawkins
- Tanja BernierTanja Bernier
- Claudia SehnerClaudia Sehner
- Eva ZellerEva Zeller
- Markus SchwindMarkus Schwind
- Thomas PfisterThomas Pfister
- Martin KohanMartin Kohan
- Osahon OsadolorOsahon Osadolor
- Milica GlogovacMilica Glogovac
- Gregor TuschlGregor Tuschl
- David G. DolanDavid G. Dolan
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 115, 104692
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Investigating outcomes associated with medication use during pregnancy: A review of methodological challenges and observational study designsReproductive Toxicology, 2012
- Analgesics During Pregnancy and CryptorchidismEpidemiology, 2011
- A review of the literature on the effects of acetaminophen on pregnancy outcomeReproductive Toxicology, 2010
- Paracetamol metabolism and related genetic differencesDrug Metabolism Reviews, 2010
- Acetaminophen Use in Pregnancy and Risk of Birth DefectsObstetrics & Gynecology, 2010
- Prenatal exposure to acetaminophen and respiratory symptoms in the first year of lifeAnnals of Allergy, Asthma & Immunology, 2008
- Acetylcysteine for Acetaminophen PoisoningNew England Journal of Medicine, 2008
- Acetaminophen use during pregnancy: effects on risk for congenital abnormalitiesAmerican Journal of Obstetrics and Gynecology, 2008
- Acetaminophen Toxicity in ChildrenPediatrics, 2001
- Clinical Pharmacokinetics of ParacetamolClinical Pharmacokinetics, 1982